Ask AI

Innovations in HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: A Practical Skills Course on New and Emerging Targeted Therapies

Enhance your understanding of targeted therapies for HER2+ gastroesophageal adenocarcinoma and biliary tract cancer based on current and emerging clinical evidence, and learn how to select patients for optimal benefit from HER2-direct therapies through an interactive decision support tool, downloadable patient checklist resource and infographic, on-demand webcast, interactive case challenges, podcasts, an expert-authored commentary, and downloadable slides.

Share

Program Content

Activities

Understanding Tx Options for HER2+ GEA and BTC
Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 24, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Smart Patients, Inc.

Supporters

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.

Partners

Smart Patients, Inc.

ProCE Banner